Time is of the essence: Coupling sleep-wake and circadian neurobiology to the antidepressant effects of ketamine Read More > November 12, 2020
Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin Read More > November 12, 2020
The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD Read More > November 9, 2020
Effect of Ketamine on Rumination in Treatment-Resistant Depressive Patients Read More > November 1, 2020
Neurocognitive impact of ketamine treatment in major depressive disorder: A review on human and animal studies – PubMed Read More > November 1, 2020
Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression Read More > October 31, 2020
Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression Read More > October 29, 2020
Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial Read More > October 29, 2020
Predicting therapeutic response to oral ketamine for chronic suicidal ideation: a Bayesian network for clinical decision support Read More > October 28, 2020
